Dr. Ortiz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 5th Ave
# 4
Pittsburgh, PA 15213Phone+1 412-648-6161Fax+1 412-624-3040
Summary
- Dr. Luis Ortiz is a pulmonologist based in Pittsburgh, PA, with a subspecialty in Fibrotic lung disease. He graduated from Pontifical Bolivarian University in 1983, completed his internal medicine residency at Tulane University and his fellowship in Pulmonary and Critical Care at the University of Texas in Houston. He has contributed to several well-cited publications in the field of lung fibrosis, and environmental health focusing on dust inhalation, macrophage activity, mesenchymal stem cells and metabolism. His research involvement includes clinical trials related to acute respiratory distress syndrome and idiopathic pulmonary fibrosis. He was awarded the CMS Meaningful Use Stage 1 Certification by Epic Systems Corporation in 2011.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Pulmonary Disease and Critical Care Medicine, 1990 - 1993
Rice UniversityPost Doctoral, Molecular Biology, 1990 - 1993
MD Anderson Cancer Center Houston Pulmonary, Pulmonary, 1990 - 1993
Tulane UniversityResidency, Internal Medicine, 1987 - 1990
Pontifical Bolivarian UniversityClass of 1983
Certifications & Licensure
GA State Medical License 1989 - 2027
PA State Medical License 2002 - 2026
TX State Medical License 1990 - 2026
LA State Medical License 1993 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2001 Oct 01
- Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2003 Jan 01
- Dorothy P. and Richard P. Simmons Center for ILD Research Registry Start of enrollment: 2003 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsMesenchymal Stem Cells from COPD Patients Are Capable of Restoring Elastase-Induced Emphysema in a Murine Experimental Model.Carlos Río, Andreas K Jahn, Aina Martin-Medina, Alba Marina Calvo Bota, Mª Teresa De Francisco Casado
International Journal of Molecular Sciences. 2023-03-18 - 19 citationsInhibition of antiapoptotic BCL-2 proteins with ABT-263 induces fibroblast apoptosis, reversing persistent pulmonary fibrosis.Joseph C Cooley, Nomin Javkhlan, Jasmine A Wilson, Daniel G Foster, Benjamin L Edelman
JCI Insight. 2023-02-08 - 57 citationsRole of metabolic reprogramming in pro-inflammatory cytokine secretion from LPS or silica-activated macrophages.Antonella Marrocco, Luis A Ortiz
Frontiers in Immunology. 2022-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
